Literature DB >> 22201858

Recent advances on tea polyphenols.

Jyoti Kanwar1, Mujtaba Taskeen, Imthiyaz Mohammad, Congde Huo, Tak Hang Chan, Qing Ping Dou.   

Abstract

Over the past decade many scientific and medical studies have focused on green tea for its long-purported health benefits. There is convincing evidence that tea is a cup of life. It has multiple preventive and therapeutic effects. This review thus focuses on the recent advances of tea polyphenols and their applications in the prevention and treatment of human cancers. Of the various polyphenols in tea, (-)-Epigallocatechin-3-gallate (EGCG) is the most abundant, and active compound studied in tea research. EGCG inhibits several molecular targets to inhibit cancer initiation and modulates several essential survival pathways to block cancer progression. Herein, we describe the various mechanisms of action of EGCG and also discuss previous and current ongoing clinical trials of EGCG and green tea polyphenols in different cancer types.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201858      PMCID: PMC3303150          DOI: 10.2741/363

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  149 in total

1.  A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.

Authors:  Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

2.  A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach.

Authors:  E Choan; Roanne Segal; Derek Jonker; Shawn Malone; Neil Reaume; Libni Eapen; Victor Gallant
Journal:  Urol Oncol       Date:  2005 Mar-Apr       Impact factor: 3.498

3.  Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion.

Authors:  C Li; M J Lee; S Sheng; X Meng; S Prabhu; B Winnik; B Huang; J Y Chung; S Yan; C T Ho; C S Yang
Journal:  Chem Res Toxicol       Date:  2000-03       Impact factor: 3.739

4.  Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility.

Authors:  Marion M Chan; Kenneth J Soprano; Kate Weinstein; Dunne Fong
Journal:  J Cell Physiol       Date:  2006-05       Impact factor: 6.384

5.  Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells.

Authors:  Atsushi Masamune; Kazuhiro Kikuta; Masahiro Satoh; Noriaki Suzuki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

6.  The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate.

Authors:  John K Jackson; Jinying Zhao; Wesley Wong; Helen M Burt
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

7.  Green tea consumption enhances survival of epithelial ovarian cancer.

Authors:  Min Zhang; Andy H Lee; Colin W Binns; Xing Xie
Journal:  Int J Cancer       Date:  2004-11-10       Impact factor: 7.396

8.  Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.

Authors:  Gyuman Park; Byung Sun Yoon; Jai-Hee Moon; Bona Kim; Eun Kyoung Jun; Sejong Oh; Hyunggee Kim; Hea Joon Song; Joo Young Noh; Chilhwan Oh; Seungkwon You
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

9.  Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs.

Authors:  Congde Huo; Huanjie Yang; Qiuzhi Cindy Cui; Q Ping Dou; Tak Hang Chan
Journal:  Bioorg Med Chem       Date:  2009-12-16       Impact factor: 3.641

10.  Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.

Authors:  Aslamuzzaman Kazi; Zhigang Wang; Naveen Kumar; Samuel C Falsetti; Tak-Hang Chan; Q Ping Dou
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

View more
  56 in total

1.  Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1.

Authors:  S Sánchez-Tena; P Vizán; P K Dudeja; J J Centelles; M Cascante
Journal:  Biochim Biophys Acta       Date:  2013-08-28

2.  Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols.

Authors:  Stephen J Glynn; Kevin J Gaffney; Marcos A Sainz; Stan G Louie; Nicos A Petasis
Journal:  Org Biomol Chem       Date:  2015-04-07       Impact factor: 3.876

Review 3.  Tea and human health: biomedical functions of tea active components and current issues.

Authors:  Zong-mao Chen; Zhi Lin
Journal:  J Zhejiang Univ Sci B       Date:  2015-02       Impact factor: 3.066

4.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

5.  Green Tea Polyphenols Protects Cochlear Hair Cells from Ototoxicity by Inhibiting Notch Signalling.

Authors:  Lin-Tao Gu; Jia Yang; Shi-Zheng Su; Wen-Wen Liu; Zhong-Gang Shi; Qi-Rong Wang
Journal:  Neurochem Res       Date:  2015-04-21       Impact factor: 3.996

Review 6.  Green tea compounds in breast cancer prevention and treatment.

Authors:  Min-Jing Li; Yan-Cun Yin; Jiao Wang; Yang-Fu Jiang
Journal:  World J Clin Oncol       Date:  2014-08-10

7.  Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases.

Authors:  Rattiyaporn Kanlaya; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

8.  (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.

Authors:  Sufang Liu; Hongde Li; Min Tang; Ya Cao
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

Review 9.  Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Roy A Jensen; Shrikant Anant
Journal:  Semin Cancer Biol       Date:  2016-09-05       Impact factor: 15.707

10.  Long-term effects of oral tea polyphenols and Lactobacillus brevis M8 on biochemical parameters, digestive enzymes, and cytokines expression in broilers.

Authors:  Hua-li Li; Zong-jun Li; Zhong-shan Wei; Ting Liu; Xiao-zuo Zou; Yong Liao; Yu Luo
Journal:  J Zhejiang Univ Sci B       Date:  2015-12       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.